In April, the members of Biotech Austria elected a new board during its official founding event. Within the last five months, Biotech Austria expanded its number of members to more than 50. European Biotechnology spoke to founding President and CEO of Apeiron Biologics, Peter Llewellyn-Davies, about the association's goals for the coming months, challenges for Austrian biotech companies and new communication approaches for that industry.